An Open-label, One-sequence Cross Over, Single Centre Trial, Investigating the Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2017
Price : $35 *
At a glance
- Drugs Semaglutide (Primary) ; Metformin; Warfarin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Novo Nordisk
- 27 Mar 2017 Results of effects of semaglutide on pharmacokinetics of concomitant medication from two phase I studies including this study published in the Clinical Pharmacokinetics
- 02 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.